SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

22 hedge funds and large institutions have $70.4M invested in Salarius Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

61% less call options, than puts

Call options by funds: $183K | Put options by funds: $465K

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$183K
Puts
$465K
Net Calls
Net Calls Change

Top Buyers

1
+$932K
2
+$889K
3
+$883K

Top Sellers

1
-$1.84M
2
-$598K
3
-$557K
4
TCIM
TIAA CREF Investment Management
New York
-$348K
5
SIM
Spark Investment Management
New York
-$341K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
1 2
3